Literature DB >> 7994859

Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy.

C Mady1, R H Cardoso, A C Barretto, P L da Luz, G Bellotti, F Pileggi.   

Abstract

BACKGROUND: The fundamental determinant of the natural history of Chagas' disease is cardiac involvement. METHODS AND
RESULTS: We studied 104 male patients with congestive heart failure due to Chagas' disease to estimate the survival distribution function and to evaluate age, functional class (FC), maximal oxygen consumption (VO2max), and ejection fraction (EF) as predictors of survival. Statistical evaluation was performed through univariate (Student's t test and chi 2 test) and multivariate analyses (Cox's regression model). Overall survival was 66% at 1 year, 56% at 3 years, and 48% at 5 years. Ages were not statistically different (P = .9811) between survivor (40.3 +/- 8.7) and nonsurvivor (40.3 +/- 9.4) groups. The ejection fraction(s) were statistically different (P = .0001) between survival (43.6 +/- 9.9) and nonsurvival (30.6 +/- 8.1) groups, as was VO2max (P = .0001) (21.0 +/- 4.7 and 15.0 +/- 4.9, respectively). Most of the surviving patients were in FC II and most of the nonsurvivors were in FC IV (P = .0001). VO2max (P = .0001) and EF (P = .0008) are highly associated with survival time in the multivariate analysis, but FC (P = .0578) is less important. Age (P = .9811) did not influence survival.
CONCLUSIONS: We conclude that 50% of the patients with heart failure due to Chagas' disease die in 47 months and that VO2max and EF are important indices of survival in this group.

Entities:  

Mesh:

Year:  1994        PMID: 7994859     DOI: 10.1161/01.cir.90.6.3098

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  31 in total

1.  Clinical aspects of Chagas disease and implications for novel therapies.

Authors:  Cristiane Menezes; Germano Carneiro Costa; Kenneth J Gollob; Walderez O Dutra
Journal:  Drug Dev Res       Date:  2011-09       Impact factor: 4.360

Review 2.  The emerging role of MRI in the diagnosis and management of cardiomyopathies.

Authors:  Carlos Eduardo Rochitte; Eduardo Marinho Tassi; Afonso Akio Shiozaki
Journal:  Curr Cardiol Rep       Date:  2006-02       Impact factor: 2.931

3.  Electrocardiographic and echocardiographic abnormalities in Chagas disease: findings in residents of rural Bolivian communities hyperendemic for Chagas disease.

Authors:  Antonio B Fernandez; Maria Carmo P Nunes; Eva H Clark; Aaron Samuels; Silvio Menacho; Jesus Gomez; Ricardo W Bozo Gutierrez; Thomas C Crawford; Robert H Gilman; Caryn Bern
Journal:  Glob Heart       Date:  2015-09

4.  Autonomic dysfunction and risk factors associated with Trypanosoma cruzi infection among children in Arequipa, Peru.

Authors:  Natalie M Bowman; Vivian Kawai; Robert H Gilman; Cesar Bocangel; Gerson Galdos-Cardenas; Lilia Cabrera; Michael Z Levy; Juan Geny Cornejo del Carpio; Freddy Delgado; Lauren Rosenthal; Vivian V Pinedo-Cancino; Francis Steurer; Amy E Seitz; James H Maguire; Caryn Bern
Journal:  Am J Trop Med Hyg       Date:  2011-01       Impact factor: 2.345

5.  Echocardiographic parameters and survival in Chagas heart disease with severe systolic dysfunction.

Authors:  Daniela do Carmo Rassi; Marcelo Luiz Campos Vieira; Ana Lúcia Martins Arruda; Viviane Tiemi Hotta; Rogério Gomes Furtado; Danilo Teixeira Rassi; Salvador Rassi
Journal:  Arq Bras Cardiol       Date:  2014-02-10       Impact factor: 2.000

6.  Urbanization, land tenure security and vector-borne Chagas disease.

Authors:  Michael Z Levy; Corentin M Barbu; Ricardo Castillo-Neyra; Victor R Quispe-Machaca; Jenny Ancca-Juarez; Patricia Escalante-Mejia; Katty Borrini-Mayori; Malwina Niemierko; Tarub S Mabud; Jere R Behrman; Cesar Naquira-Velarde
Journal:  Proc Biol Sci       Date:  2014-08-22       Impact factor: 5.349

Review 7.  Interferon-γ and other inflammatory mediators in cardiomyocyte signaling during Chagas disease cardiomyopathy.

Authors:  Ludmila Rodrigues Pinto Ferreira; Amanda Farage Frade; Monique Andrade Baron; Isabela Cunha Navarro; Jorge Kalil; Christophe Chevillard; Edecio Cunha-Neto
Journal:  World J Cardiol       Date:  2014-08-26

8.  Neuromuscular electrical stimulation in a patient with chronic heart failure due to chagas disease: a case report.

Authors:  Hugo Souza Bittencourt; Erenaldo de Souza Rodrigues Junior; Cristiano Gonçalves da Cruz; Alessandro Mezzani; Francisco José Farias Borges dos Reis; Vitor Oliveira Carvalho
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 9.  Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy.

Authors:  Claudio A Muratore; Adrian Baranchuk
Journal:  Vasc Health Risk Manag       Date:  2010-08-09

10.  Mode of death on Chagas heart disease: comparison with other etiologies. a subanalysis of the REMADHE prospective trial.

Authors:  Silvia M Ayub-Ferreira; Sandrigo Mangini; Victor S Issa; Fátima D Cruz; Fernando Bacal; Guilherme V Guimarães; Paulo R Chizzola; Germano E Conceição-Souza; Fabiana G Marcondes-Braga; Edimar A Bocchi
Journal:  PLoS Negl Trop Dis       Date:  2013-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.